Comparative genomic hybridization analysis of Wilms tumors.
In this study we have applied the technique of comparative genomic hybridization (CGH) to a large series of sporadic Wilms tumors, including six samples of the associated nephroblastomatosis. The data obtained were compared with the findings of molecular studies carried out on the same material. The aims of the study were (1) to characterize the range of genetic variation in sporadic Wilms tumor and nephroblastomatosis, (2) to determine whether changes could be found that have not been detected by commonly used techniques, and (3) to compare the sensitivity of CGH with that of conventional molecular analysis. The chromosomes that showed gains and losses by CGH were similar to those previously found in molecular and cytogenetic studies, however loss of 4q was a new event identified in 2 out of 46 tumors. We did not detect amplified genetic material. Comparison of the data from the nephroblastomatosis and tumor samples from the same patient showed that loss of 7p may be associated with malignant transformation, and that losses in 1p, 11p, 4q and gains in 1q and 12q can be early events; whilst loss in 9p and gain of 8, 10q and 18 are possible secondary changes in tumor development. The combined CGH and molecular techniques used demonstrated involvement of two specific 1p regions in the etiology of Wilms tumor.
Steenman
M
M
Institute of Human Genetics, University of Amsterdam, The Netherlands. m.steenman@amc.uva.nl
Redeker
B
B
de Meulemeester
M
M
Wiesmeijer
K
K
Voûte
P A
PA
Westerveld
A
A
Slater
R
R
Mannens
M
M
D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D002877:Chromosomes, Human / Q000235:genetics / Q000648:ultrastructure; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics / Q000648:ultrastructure; D005260:Female; D016162:Genes, Wilms Tumor; D005819:Genetic Markers; D005821:Genetic Techniques; D014644:Genetic Variation; D015894:Genome, Human; D006579:Heterozygote; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D007680:Kidney Neoplasms / Q000235:genetics*; D008297:Male; D009396:Wilms Tumor / Q000235:genetics*
D005819:Genetic Markers